Solvay introduces three medical grade filaments to portfolio

Written by Georgi Makin

The filaments will reportedly be suitable for limited contact applications and will be available immediately in Europe and North America. Solvay (Bollate, Italy) has announced the introduction of three new filaments to their high-performance portfolio, for use in the healthcare industry. The filaments include a neat KetaSpire® polyetheretherketone (PEEK) AM filament (NT1 HC), a 10-percent carbon fibre reinforced KetaSpire® PEEK AM filament (CF10 HC) and a neat Radel® polyphenylsulfone (PPSU) AM filament (NT1 HC). The filaments will reportedly be suitable for limited contact applications, specifically for less than 24 hour bodily fluid or tissue contact, and will be available immediately...

To view this content, please register now for access

It's completely free